Shiga Toxin: Biochemistry, Genetics, Mode of Action, and Role in Pathogenesis

  • A. D. O’brien
  • V. L. Tesh
  • A. Donohue-Rolfe
  • M. P. Jackson
  • S. Olsnes
  • K. Sandvig
  • A. A. Lindberg
  • G. T. Keusch
Part of the Current Topics in Microbiology and Immunology book series (CT MICROBIOLOGY, volume 180)


Dysentery was well known and clearly described in many ancient texts and histories. The first step towards the description of the genus Shigella, however, was the identification of Entamoeba histolytica by Losch in 1875 and the separation of amebic from all other forms of dysentery (Losch, 1875). With this discovery, attention could be focused on the etiology of epidemic dysentery, and a partial description of the prototype Shigella sp., Shigella dysenteriae type 1, was published by Chantemesse and Widal in 1888. The definitive description of this organism was provided by Kiyoshi Shiga following an extensive dysentery epidemic in Japan in 1896 (Shiga 1898). It did not take long to determine that there was a potent toxic activity in this organism, and in 1900 Flexner reported that either living or killed cultures of Shiga’s bacillus injected into the peritoneal cavity of animals caused fever and diarrhea. Flexner concluded that shigellosis was due to a “toxic agent rather than to an infection per se”; however, the Observed effects were Probably due to endotoxin. The presence of a lethal toxin in extracts of heat-killed bacteria was shown independently by Neisser and Shiga (1903) and by Conradi (1903). Conradi (1903) also described the limb paralysis following parenteral inoculation of Shigella extracts in rabbits, characteristic of the so-called Shiga neurotoxin.


Shiga Toxin Human Vascular Endothelial Cell Shigella Dysenteriae Hemorrhagic Colitis Rabbit Jejunum 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Acheson DWK, Donohue-Rolfe A (1989) Cancer associated hemolytic uremic syndrome. A possible role of mitomycin C in relation to Shiga-like toxins. J Clin Oncol 7:1943PubMedGoogle Scholar
  2. Acheson DWK, Muhldorfer I, Kane A, Keusch GT, Donohue-Rolfe A (1990) Bacteriophage induction as a cause of increased Shiga-like toxin synthesis in E coli. Abstracts of the Annual meeting of the American Society for Microbiology Washington, DC, p 61Google Scholar
  3. Barrett TJ, Potter ME, Wachsmuth IK (1989a) Continuous peritoneal infusion of Shiga-like toxin II (SLT II) as a model for SLT ll-induced diseases. J Infect Dis 159: 774–777PubMedCrossRefGoogle Scholar
  4. Barrett TJ, Potter ME, Wachsmuth IK (1989b) Bacterial endotoxin both enhances and inhibits the toxicity of Shiga-like toxin II in rabbits and mice. Infect Immun 57: 3434–3437PubMedGoogle Scholar
  5. Betley MJ, Miller VL, Mekalanos JJ (1986) Genetics of bacterial enterotoxins. Annu Rev Microbiol 40: 577–605PubMedCrossRefGoogle Scholar
  6. Bevilacqua MP, Pober JS, Majeau GR, Cotran RS, Gimbrone MA Jr (1984) Interleukin (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells. J Exp Med 160: 618–623PubMedCrossRefGoogle Scholar
  7. Bevilacqua MP, Pober JS, Wheeler ME, Cotran RS, Gimbrone MA Jr (1985) Interleukin-1 acts on cultured human vascular endothelial cells to increase the adhesion of polymorphonuclear leukocytes, monocytes, and related cell lines. J Clin Invest 76: 2003–2011Google Scholar
  8. Bevilacqua MP, Pober JS, Majeau GR, Fiers W, Cotran RS, Gimbrone MA Jr (1986) Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the action of interleukin 1. Proc Natl Acad Sci USA 83: 4533–4537PubMedCrossRefGoogle Scholar
  9. Bopp CA, Greene KD, Downes F, Sowers EG, Wells JG, Wachsmuth IK (1987) Unusual verotoxin-producing Escherichia coli associated with hemorrhagic colitis. J Clin Microbiol 25: 1485–1489Google Scholar
  10. Bridgwater FAJ, Morgan RS, Rowson KEK, Payling-Wright G (1955) The neurotoxin of Shigella shigae. Morphological and functional lesions produced in the central nervous system of rabbits. Br J Exp Pathol 36: 447–453PubMedGoogle Scholar
  11. Brown JE, Ussery MA, Leppla SH, Rothman SW (1980) Inhibition of protein synthesis by Shiga toxin. Activation of toxin and inhibition of peptide elongation. FEBS Lett 117: 84–88PubMedCrossRefGoogle Scholar
  12. Brown JE, Griffin DE, Rothman SW, Doctor BP (1982) Purification and biological characterization of Shiga toxin for Shigella dyseriteriae. Infect Immun 36: 996–1005PubMedGoogle Scholar
  13. Brown JE, Karlsson K-A, Lindberg A, Stromberg N, Thurin J (1983) Identification of the receptor glycolipid for the toxin of Shigella dyseriteriae. In: Chester MA, Heinegaard D, Lundblad A, Svensson S (eds.) Proceedings of the 7th International Symposium on Glycoconjugates. Rahms i Lund, Lund, Sweden, pp 678–679Google Scholar
  14. Calderwood SB, Mekalanos JJ (1987) Iron regulation of Shiga-like toxin expression in Escherichia coli is mediated by the fur locus. J Bacteriol 169: 4759–4764PubMedGoogle Scholar
  15. Calderwood SB, Mekalanos JJ (1988) Confirmation of the Fur operator site by insertion of a synthetic oligonucleotide into an operon fusion plasmid. J Bacteriol 170:1015–1017PubMedGoogle Scholar
  16. Calderwood SB, AuClair F, Donohue-Rolfe A, Keusch GT, Mekalanos JJ (1987) Nucleotide sequence of the Shiga-like toxin genes ofEscherichia coli. Proc Natl Acad Sci USA 84: 4364–4368PubMedCrossRefGoogle Scholar
  17. Calderwood SB, Acheson DWK, Goldberg MB, Boyko SA, Donohue-Rolfe A (1990) A system of production and rapid purification of large amounts of the Shiga toxin/Shiga-like toxin I B subunit. Infect Immun 58: 2977–2982PubMedGoogle Scholar
  18. Carter AO, Borczyk AA, Carlson JAK, Harvey B, Hockin JC, Karmali MA, Krishnan C, Kron DA, Lior H (1987) A severe outbreak of Escherichia coli 0157: H7-associated hemorrhagic colitis in a nursing home. N Engl J Med 317: 1496–1500PubMedCrossRefGoogle Scholar
  19. Cavender DE, Haskard DO, Joseph B, Ziff M (1986) Interleukin 1 increases the binding of human B and T lymphocytes to endothelial cell monolayers. J Immunol 136: 203–207PubMedGoogle Scholar
  20. Chantemesse A, Widal F (1888) Sur les microbes de la dysenteria epidemique. Bull Acad Med (Paris) 19:522–529Google Scholar
  21. Cleary TG, Lopez EL (1989) The Shiga-like toxin-producing Escherichia coli and hemolytic uremic syndrome. Pediatr Infect Dis J 8: 720–724PubMedCrossRefGoogle Scholar
  22. Cohen A, Hannigan GE, Williams BRG, Lingwood CA (1987) Roles of globotriosyl- and galabio- sylceramide in Verotoxin binding and high affinity interferon receptor. J Biol Chem 262:17088–17091PubMedGoogle Scholar
  23. Conradi H (1903) Über lösliche, durch aseptische Autolyse erhaltene Giftstoffe von Ruhr- und Typhus-Bazillen. Dtsch Med Wochenschr 29: 26–28CrossRefGoogle Scholar
  24. Davis CG, van Driel IR, Russell DW, Brown MS, Goldstein JL (1987) The low density lipoprotein receptor. Identification of amino acids in cytoplasmic domain required for rapid endocytosis. J Biol Chem 262: 4075–4082PubMedGoogle Scholar
  25. DeGrandis S, Ginsberg J, Toone M, Climie S, Friesen J, Brunton J (1987) Nucleotide sequence and promoter mapping of the Escherichia coli Shiga-like toxin operon of bacteriophage H-19B. J Bacteriol 169:4313–4319PubMedGoogle Scholar
  26. DeGrandis S, Law H, Brunton J, Gyles C, Lingwood CA (1989) Globotetraosyl ceramide is recognized by the pig edema disease toxin. J Biol Chem 264: 12520–12525Google Scholar
  27. Donaldson JG, Lippincott-Schwartz J, Bloom GS, Kreis TE, Klausner RD (1990) Dissociation of a 110-kD peripheral membrane protein from the Golgi apparatus is an early event in brefeldin A action. J Cell Biol 111: 2295–2306PubMedCrossRefGoogle Scholar
  28. Donnenberg MS, Donohue-Rolfe A, Kesch GT (1989) Epithelial cell invasion: an overlooked property of enteropathogenic Escherichia coli (EPEC) associated with the EPEC adherence factor. J Infect Dis 160: 452–459PubMedCrossRefGoogle Scholar
  29. Donohue-Rolfe A, Keusch GT (1983) Shigella dyseriteriae 1 cytotoxin: periplasmic protein releasable by polymyxin B and osmotic shock. Infect Immun 39: 270–274PubMedGoogle Scholar
  30. Donohue-Rolfe A, Keusch GT, Edson C, Thorley-Lawson D, Jacewicz M (1984) Pathogenesis of shigella diarrhea. IX. Simplified high yield purification of shigella toxin and characterization of subunit composition and function by the use of subunit-specific monoclonal and polyclonal antibodies. J Exp Med 160: 1767–1781CrossRefGoogle Scholar
  31. Donohue-Rolfe A, Acheson DWK, Kane AV, Keusch GT (1989a) Purification of Shiga toxin and Shiga-like toxins I and II by receptor analog affinity chromatography with immobilized P1 glycoprotein and production of cross-reactive monoclonal antibodies. Infect Immun 56: 3888–3893Google Scholar
  32. Donohue-Rolfe A, Jacewicz M, Keusch GT (1989b) Isolation and characterization of functional Shiga toxin subunits and renatured holotoxins. Mol Microbiol 3:1231–1236Google Scholar
  33. Dubos RJ, Geiger JW (1946) Preparation and properties of Shiga toxin and toxoid. J Exp Med 84: 143–156CrossRefGoogle Scholar
  34. Dunn WA, Hubbard AL, Aronson NN Jr (1980) Low temperature selectively inhibits fusion between pinocytic vesicles and lysosomes during heterophagy of 125l-asialofetuin by the perfused rat liver. J Biol Chem 255: 5971–5978PubMedGoogle Scholar
  35. Endo Y, Tsurugi K (1988) The RNA N-glycosidase activity of ricin A-chain. The characteristics of the enzymatic activity of ricin A-chain with ribosomes and with rRNA. J Biol Chem 263: 8735–8739PubMedGoogle Scholar
  36. Endo Y, Tsurugi K, Yutsudo T, Takeda Y, Ogasawara T, Igarashi K (1988) Site of action of Vero toxin (VT2) from Escherichia coli 0157: H7 and of Shiga toxin on eukaryotic ribosomes. RNA N-glycosidase activity of the toxins. Eur J Biochem 171: 45–50PubMedCrossRefGoogle Scholar
  37. Fernandez-Puentes C, Benson S, Olsnes S, Pihl A (1976) Protective effect of elongation factor 2 on the inactivation of ribosomes by the toxic lectins abrin and ricin. Eur J Biochem 64: 437–443PubMedCrossRefGoogle Scholar
  38. Flexner S (1990) On the etiology of tropical dysentery. Bull Johns Hopkins Hosp 11: 231–242Google Scholar
  39. Fontaine A, Arondel J, Sansonetti PJ (1988) Role of Shiga toxin in the pathogenesis of bacillary dysentery studied using a tox” mutant of Shigella dysenteriae 1. Infect Immun 56: 3099–3109PubMedGoogle Scholar
  40. Francis DH, Moxley RA, Andraos CY (1989) Edema disease-like brain lesions in gnotobiotic piglets infected with Escherichia coli serotype 0157: H7. Infect Immun 57: 1339–1342PubMedGoogle Scholar
  41. Frankel A, Schlossman D, Welsh P, Hertler A, Withers D, Johnston S (1989) Selection and characterization of ricin toxin A-chain mutations in Saccharomyces cerevisiae. Mol Cell Biol 9: 415–420PubMedGoogle Scholar
  42. Fuchs G, Mobassaleh M, Donohue-Rolfe A, Montgomery RK, Grand RJ, Keusch GT (1986) Pathogenesis of Shigella diarrhea: rabbit intestinal cell microvillus membrane binding site for Shigella toxin. Infect Immun 53: 372–377PubMedGoogle Scholar
  43. Gamble JR, Harlan JM, Klebanoff SJ, Vadas MA (1985) Stimulation of adherence of neutrophils to umbilical vein endotheliun by human recombinant tumor necrosis factor. Proc Natl Acad Sci USA 82: 8667–8671PubMedCrossRefGoogle Scholar
  44. Gannon VPJ, Teerling C, Masrei SA, Gyles CL (1990) Molecular cloning and nucleotide sequence of another variant of the Escherichia coli Shiga-like toxin II family. J Gen Microbiol 136: 1125–1135PubMedGoogle Scholar
  45. Gemski P, Takeuchi A, Washington O, Formal SB (1972) Shigellosis due to Shigella dysenteriae 1: relative importance of mucosal invasion versus toxin production in pathogenesis. J Infect Dis 126: 523–530PubMedCrossRefGoogle Scholar
  46. Gill DM (1976) The arrangements of subunits in cholera toxin. Biochemistry 15:1242–1248PubMedCrossRefGoogle Scholar
  47. Gordon VM, Leppla SH, Hewlett EL (1988) Inhibitors of receptor-mediated endocytosis block the entry of Bacillus anthracis adenylate cyclase toxin but not that of Bordetella pertussis adenylate cyclase toxin. Infect Immun 56:1066–1069PubMedGoogle Scholar
  48. Griffin PM, Olmstead LC, Petras RE (1990) Escherichia coli 0157: H7-associated colitis. A clinical and histological study of 11 cases. Gastroenterology 99:142–149PubMedGoogle Scholar
  49. Gyles CL, DeGrandis SA, MacKenzie C, Brunton JL (1988) Cloning and nucleotide sequence analysis of the genes determining verocytotoxin production in a porcine edema disease isolate of Escherichia coli. Microb Pathog 5: 419–426PubMedCrossRefGoogle Scholar
  50. Hart PJ, Monzingo AF, Donohue-Rolfe A, Keusch GT, Calderwood SB, Robertus JD (1991) Crystallization of the B chain of Shiga-like toxin I from Escherichia coli. J Mol Biol 218: 691–694PubMedCrossRefGoogle Scholar
  51. Heuser J (1989) Changes in lysosome shape and distribution correlated with changes in cytoplasmic pH. J Cell Biol 108: 855–864PubMedCrossRefGoogle Scholar
  52. Hovde CJ, Calderwood SB, Mekalanos JJ, Collier RJ (1988) Evidence that glutamic acid 167 is an active-site residue of Shiga-like toxin I. Proc Natl Acad Sci USA 85: 2568–2572PubMedCrossRefGoogle Scholar
  53. Howard JG (1955) Observations on the intoxication produced in mice and rabbits by the neurotoxin of Shigella shigae. Br J Exp Pathol 36: 439–446PubMedGoogle Scholar
  54. Huang A, DeGrandis S, Friesen J, Karmali M, Congi R, Brunton JL (1986) Cloning and expression of the genes specifying Shiga-like toxin production inEscherichia coli H19. J Bacteriol 166: 375–379PubMedGoogle Scholar
  55. Huang A, Friesen J, Brunton JL (1987) Characterization of a bacteriophage that carries the genes for production of Shiga-like toxin 1 in Escherichia coli. J Bacteriol 169: 4308–4312PubMedGoogle Scholar
  56. Hunt CM, Harvey JA, Youngs ER, Irwin ST, Reid TM (1989) Clinical and pathological variability of infection by enterohaemorrhagic (Vero cytotoxin producing) Escherichia coli. J Clin Pathol 42: 847–852PubMedCrossRefGoogle Scholar
  57. Ito H, Yutsudo T, Hirayama T, Takeda Y (1988) Isolation and some properties of A and B subunits of Vero toxin 2 and in vitro formation of hybrid toxins between subunits of Vero toxin 1 and Vero toxin 2 from Escherichia coli 0157: H7. Microb Pathog 5:189–195PubMedCrossRefGoogle Scholar
  58. Ito H, Terai A, Kurazono H, Takeda Y, Nishibuchi M (1990) Cloning and nucleotide sequencing of Vero toxin 2 variant genes from the Escherichia coli 091: H21 isolated from a patient with the hemolytic uremic syndrome. Microb Pathog 8: 47–60PubMedCrossRefGoogle Scholar
  59. Jacewicz M, Clausen H, Nudelman E, Donohue-Rolfe A, Keusch GT (1986) Pathogenesis of shigella diarrhea. XI. Isolation of shigella toxin-binding glycolipid from rabbit jejunum and HeLa cells and its identification as globotriaosyl-ceramide. J Exp Med 163:1391–1404PubMedCrossRefGoogle Scholar
  60. Jacewicz M, Feldman HA, Donohue-Rolfe A, Balasubramanian KA, Keusch GT (1989) Pathogenesis of Shigella diarrhea. XIV. Analysis of Shiga toxin receptors on cloned HeLa cells. J Infect Dis 159: 881–889PubMedCrossRefGoogle Scholar
  61. Jacewicz MS, Gross SK, Mobassaleh M, Balasubramanian KA, Daniel P, McCluer RH, Keusch GT (1991) Pathogenesis of Shigella diarrhea. The relationship between Gb3 content of HeLa cells and their sensitivity to Shiga toxin, (manuscript submitted) Jackson MP (1990) Structure-function analyses of Shiga toxin and the Shiga-like toxins. Microb Pathog 8: 235–242Google Scholar
  62. Jackson MP, Neill RJ, O’Brien AD, Holmes RK, Newland JW (1987a) Nucleotide sequence analysis and comparison of the structural genes for Shiga-like toxin I and Shiga-like toxin II encoded by bacteriophages from Escherichia coli 933. FEMS Lett 44:109–114CrossRefGoogle Scholar
  63. Jackson MP, Newland JW, Holmes RK, O’Brien AD (1987b) Nucleotide sequence analysis of the structural genes for Shiga-like toxin I encoded by bacteriophage 933J from Escherichia coli. Microb Pathog 2:147–153PubMedCrossRefGoogle Scholar
  64. Jackson MP, Deresiewicz RL, Calderwood SB (1990a) Mutational analysis of the Shiga toxin and Shiga-like toxin II enzymatic subunits. J Bacteriol 172: 3346–3350PubMedGoogle Scholar
  65. Jackson MP, Wadolkowski EA, Weinstein DL, Holmes RK, O’Brien AD (1990b) Functional analysis of the Shiga toxin and Shiga-like toxin type II variant binding subunits using site-directed mutagenesis. J Bacteriol 172: 653–658PubMedGoogle Scholar
  66. Jerse AE, Yu J, Tall BD, Kaper JH (1990) A genetic locus of enteropathogenic Escherichia coli necessary for the production of attaching and effacing lesions on tissue culture cells. Proc Natl Acad Sci USA 87: 7839–7843PubMedCrossRefGoogle Scholar
  67. Johnson WM, Lior H, Bezanson GS (1983) Cytotoxic Escherichia coli 0157: H7 associated with haemorrhagic colitis in Canada. Lancet i: 76CrossRefGoogle Scholar
  68. Kandel G, Donohue-Rolfe A, Donowitz M, Keusch GT (1989) Pathogenesis of Shigella diarrhea. XVI. Selective targeting of Shiga toxin to villus cells of rabbit jejunum explains the effect of the toxin on intestinal electrolyte transport. J Clin Invest 84:1509–1517PubMedCrossRefGoogle Scholar
  69. Karch H, Bitzan M, Pietsch R, Stenger K-O, von Wulften H, Heesemann J, Dusing R (1988) Purified verotoxins of Escherichia coli 0157: H7 decrease prostacyclin synthesis by endothelial cells. Microb Pathog 5: 215–221PubMedCrossRefGoogle Scholar
  70. Karmali MA, Steele BT, Petric M, Lim C (1983) Sporadic cases of hemolytic uremic syndrome associated with fecal cytotoxin and cytotoxin-producing Escherichia coli. Lancet 1: 619–620PubMedCrossRefGoogle Scholar
  71. Karmali MA, Petric M, Lim C, Fleming PC, Arbus GS, Lior H (1985) The association between hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli. J Infect Dis 151:775–782PubMedCrossRefGoogle Scholar
  72. Kavi J, Wise R (1989) Causes of the hemolytic uraemic syndrome. Br Med J 298: 65–66CrossRefGoogle Scholar
  73. Keenan KP, Sharpnack DD, Collins H, Formal SB, O’Brien AD (1986) Morphologic evaluation of the effects of Shiga toxin and Escherichia coli Shiga-like toxin on the rabbit intestine. Am J Pathol 125: 69–80PubMedGoogle Scholar
  74. Keusch GT (1981) Receptor-mediated endocytosis of Shigella cytotoxin. In: Middlebrook JL, Kohn LD (eds) Receptor-mediated binding and internalization of toxins and hormones. Academic, New York; pp 95–112Google Scholar
  75. Keusch GT, Jacewicz M (1977) Pathogenesis of Shigella diarrhea. VII. Evidence for a cell membrane toxin receptor involving β?1–4 linked N-acetyl-D-glucosamine oligomers. J Exp Med 146: 535–546PubMedCrossRefGoogle Scholar
  76. Keusch GT, Grady GF, Mata LJ, Mclver J (1972a) The pathogenesis of Shigella diarrhea. I. Enterotoxin production by Shigella dysenteriae 1. J Clin Invest 51:1212–1218PubMedCrossRefGoogle Scholar
  77. Keusch GT, Grady GF, Takeuchi A, Sprinz H (1972b) The pathogenesis of Shigella diarrhea. II. Enterotoxin induced acute enteritis in the rabbit ileum. J Infect Dis 126: 92–95PubMedCrossRefGoogle Scholar
  78. Keusch GT, Donohue-Rolfe A, Jacewicz M (1986a) Shigella toxin(s): description and role in diarrhea and dysentery. In: Dorner F, Drews J (eds) Pharmacology of bacterial toxins. Pergamon, Oxford pp 235–270Google Scholar
  79. Keusch GT, Jacewicz M, Donohue-Rolfe A (1986b) Pathogenesis of Shigella diarrhea: evidence for N-linked glycoprotein Shigella receptors and receptor modulation by ß-galactosidase. J Infect Dis 153: 238–248PubMedCrossRefGoogle Scholar
  80. Keusch GT, Donohue-Rolfe A, Jacewicz M, Kane AV (1988) Shiga toxin: production and purification. In: Harshman S (ed) Methods in enzymology, vol 165. Microbial toxins: tools in enzymology. Academic, San Diego, 152(62): 399–401Google Scholar
  81. Kleanthous H, Smith HR, Scotland SM, Gross RJ, Rowe B, Taylor CM, Milford DV (1990) Haemolytic uraemic syndromes in the British isles, 1985–8: association with Verocytotoxin-producing Escherichia coli. Part 2: microbiological aspects. Arch Dis Child 65: 722–727PubMedCrossRefGoogle Scholar
  82. Konowalchuk J, Speir Jl, Stavric S (1977) Vero response to a cytotoxin of Escherichia coli. Infect Immun 18:775–779PubMedGoogle Scholar
  83. Konowalchuk J, Dickie N, Stavric S, Speir Jl (1978) Comparative studies of five heat-labile toxic products of Escherichia coli. Infect Immun 22: 644–648PubMedGoogle Scholar
  84. Kozlov YV, Kabishev AA, Fedchenko VI, Bayev AA (1987) Cloning and sequencing of Shiga-toxin structural genes. Proc Acad Sci USSR 295: 740–744Google Scholar
  85. Kozlov YV, Kabishev AA, Lukyanov EV, Bayev AA (1988) The primary structure of operons coding forShigella dysenteriae toxin and temperate phage H30 Shiga-like toxin. Gene 67: 213–221PubMedCrossRefGoogle Scholar
  86. Lesesne JB, Rothschild N, Erickson B, Korec S, Sisk R, Keller J, Arbus M, Woolley PV, Chiazze L, Schein PS, Neefe JR (1989) Cancer-associated hemolytic-uremic syndrome: an analysis of 85 cases from a national registry. J Clin Oncol 7: 781–789PubMedGoogle Scholar
  87. Levine MM (1987) Escherichia coli that cause diarrhea: enterotoxigenic, enteropathogenic, entero-invasive, enterohemorrhagic, and enteroadherent. J Infect Dis 155: 377–389PubMedCrossRefGoogle Scholar
  88. Levine MM, DuPont HL, Formal SB, Hornick RB, Takeuchi A, Gangarosa EJ, Snyder MJ Libonati JP (1973) Pathogenesis of Shigella dysenteriae 1 (Shiga) dysentery. J Infect Dis 127: 261–270PubMedCrossRefGoogle Scholar
  89. Lindberg AA, Brown JE, Stromberg N, Westling-Ryd M, Schultz JE, Karlsson KA (1987) Identification of the carbohydrate receptor for Shiga toxin produced by Shigella dysenteriae type 1. J. Biol Chem 262:1779–1785PubMedGoogle Scholar
  90. Linggood MA, Thompson JM (1987) Verotoxin production among porcine strains of Escherichia coli and its association with oedema disease. J Med Microbiol 25: 359–362CrossRefGoogle Scholar
  91. Lingwood CA, Law H, Richardson S, Petric M, Brunton JL, Karmali M (1987) Glycolipid binding of purified and recombinant Escherichia coli produced Verotoxin in vitro. J Biol Chem 262: 8834–8839Google Scholar
  92. Lippincott-Schwartz J, Yuan LC, Bonifacino JS, Klausner RD (1989) Rapid redistribution of Golgi proteins into the ER in cells treated with brefeldin A: evidence for membrane cycling from Golgi to ER. Cell 56:801–813PubMedCrossRefGoogle Scholar
  93. Ljungh A, Erickson M, Erickson O, Henter Jl, Wadstrom T (1988) Shiga-like toxin production and connective tissue protein binding of Escherichia coli isolated from a patient with ulcerative colitis. Scand J Infect Dis 20: 443–446PubMedCrossRefGoogle Scholar
  94. Losch F (1875) Massenhafte Entwickelung von Aeroben im Dickdarm. Arch Pathol Anat Physiol 65: 196–211CrossRefGoogle Scholar
  95. MacLeod DL, Gyles CL (1990) Purification and characterization of an Escherichia coli Shiga-like toxin II variant. Infect Immun 58:1232–1239PubMedGoogle Scholar
  96. Marques LRM, Peiris JSM, Cryz SJ, O’Brien AD (1987) Escherichia coli strains isolated from pigs with edema disease produce a variant of Shiga-like toxin II. FEMS Lett 44: 33–38CrossRefGoogle Scholar
  97. Maurelli AT, Blackmon B, Curtiss R III (1984) Temperature-dependent expression of virulence genes in Shigella species. Infect Immun 43:195–201PubMedGoogle Scholar
  98. Milford DV, Taylor CM (1990) New insights into the hemolytic uraemic syndromes. Arch Dis Child 65:713–715PubMedCrossRefGoogle Scholar
  99. Milford DV, Taylor CM, Guttridge B, Hall S, Rowe B, Kleanthous H (1990) Haemolytic uraemic syndromes in the British isles, 1985–8: association with Verocytotoxin producing Escherichia coli. Part 1: clinical and epidemiologic aspects, Arch Dis Child 65: 716–721PubMedCrossRefGoogle Scholar
  100. Moazed D, Robertson JM, Noller HF (1988) Interaction of elongation factors EF-G and EF-Tu with a conserved loop in 23S RNA. Nature 334: 362–364PubMedCrossRefGoogle Scholar
  101. Mobassaleh M, Donohue-Rolfe A, Jacewicz M, Grand RJ, Keusch GT (1988) Pathogenesis of Shigella diarrhea: evidence for a developmentally regulated glycolipid receptor for Shigella toxin involved in the fluid secretory response of rabbit small intestine. J Infect Dis 157:1023–1031PubMedCrossRefGoogle Scholar
  102. Mobassaleh M, Gross SK, McCluer RH, Donohue-Rolfe A, Keusch GT (1989) Quantitation of the rabbit intestinal glycolipid receptor for Shiga toxin. Further evidence for the developmental regulation of globotriaosylceramide in microvillus membranes. Gastroenterology 97: 384–391PubMedGoogle Scholar
  103. Mobassaleh M, Gross SK, McCluer RH, Keusch GT (1991) Distribution, subcellular localization and elucidation of the development regulation of Shiga toxin receptor synthesis in rabbit small intestine. Abstracts of the annual meeting of the American Gastroenterological Association, WashingtonGoogle Scholar
  104. Montesano R, Roth J, Robert A, Orci L (1982) Non-coated membrane invaginations are involved in binding internalization of cholera and tetanus toxins. Nature 296: 651–653PubMedCrossRefGoogle Scholar
  105. Montfort W, Villafranca JE, Monzingo AF, Ernst SR, Katzin B, Rutenber E, Xuong NH, Hamlin R, Robertus JD (1987) The three-dimensional structure of ricin at 2.8Á. J Biol Chem 262: 5398–5403PubMedGoogle Scholar
  106. Moyer MP, Dixon PS, Rothman SW, Brown JE (1987) Cytotoxicity of Shiga toxin for primary cultures of human colonic and ileal epithelial cells. Infect Immun 55: 1533–1535PubMedGoogle Scholar
  107. Nachman RL, Hajjar KA, Silverstein RL, Dinarello CA (1986) Interleukin 1 induces endothelial cell synthesis of plasminogen activator inhibitor. J Exp Med 163: 1595–1604PubMedCrossRefGoogle Scholar
  108. Nawroth PP, Stern DM (1986) Modulation of endothelial cell hemostatic properties by tumor necrosis factor. J Exp Med 163: 740–745PubMedCrossRefGoogle Scholar
  109. Neill RJ, Gemski P, Formal SB, Newland JW (1988) Deletion of the Shiga toxin gene in a chlorate-resistant derivative of Shigella dyseriteriae type 1 that retains virulence. J Infect Dis 158: 737–741PubMedCrossRefGoogle Scholar
  110. Neisser M, Shiga K (1903) Lieber freie Receptoren von Typhus- und Dysenterie-Bazillen und ueber das Dysenterie Toxin. Dtsch Med Wochenschr 29: 61–62CrossRefGoogle Scholar
  111. Newland JW, Neill RJ (1988) DNA probes for Shiga-like toxins I and II and for toxin-converting bacteriophage. J Clin Microbiol 26: 1292–1297PubMedGoogle Scholar
  112. Newland JW, Strockbine NA, Miller SF, O’Brien AD, Holmes RK (1985) Cloning of Shiga-like toxin structural genes from a toxin converting phage ofEscherichia coli. Science 230: 179–181PubMedCrossRefGoogle Scholar
  113. Newland JW, Strockbine NA, Neill RJ (1987) Cloning of genes for production of Escherichia coli Shiga-like toxin type II. Infect Immun 55: 2675–2680PubMedGoogle Scholar
  114. O’Brien AD, Holmes RK (1987) Shiga and Shiga-like toxins. Microbiol Rev 51: 206–220PubMedGoogle Scholar
  115. O’Brien AD, LaVeck GD (1983) Purification and characterization of a Shigella dyseriteriae 1–like toxin produced by Escherichia coli. Infect Immun 40: 675–683PubMedGoogle Scholar
  116. O’Brien AD, LaVeck GD, Griffin DE, Thompson MR (1980) Characterization of Shigella dyseriteriae 1 (Shiga) toxin purified by anti-Shiga toxin affinity chromatography. Infect Immun 30: 380–384Google Scholar
  117. O’Brien AD, LaVeck GD, Thompson MR, Formal SB (1982) Production of Shigella dyseriteriae type 1 -like cytotoxin by Escherichia coli. J Infect Dis 146: 763–769PubMedCrossRefGoogle Scholar
  118. O’Brien AD, Lively TA, Chen ME, Rothman SW, Formal SB (1983) Escherichia coli 0157: H7 strains associated with haemorrhagic colitis in the United States produce Shigella dyseriteriae 1 (Shiga) like cytotoxin. Lancet 1: 702PubMedCrossRefGoogle Scholar
  119. O’Brien AD, Newland JW, Miller SF, Holmes RK, Smith HW, Formal SB (1984) Shiga-like toxin- converting phages fromEscherichia coli strains that cause hemorrhagic colitis or infantile diarrhea. Science 226: 694–696PubMedCrossRefGoogle Scholar
  120. O’Brien AD, Marques LRM, Kerry CF, Newland JW, Holmes RK (1989) Shiga-like toxin converting phage of enterohemorrhagic Escherichia coli strain 933. Microb Pathog 6: 381–390PubMedCrossRefGoogle Scholar
  121. Obrig TG, Moran TP, Brown JE (1987) The mode of action of Shiga toxin on peptide elongation of eukaryotic protein synthesis. Biochem J 244: 287–294PubMedGoogle Scholar
  122. Obrig TG, DelVecchio PJ, Brown JE, Moran TP, Rowland BM, Judge TK, Rothman SW (1988) Direct cytotoxic action of Shiga toxin on human vascular endothelial cells. Infect Immun 56: 2373–2378PubMedGoogle Scholar
  123. Olsnes S, Eiklid K (1980) Isolation and characterization of Shigella shigae cytotoxin. J Biol Chem 225: 284–289Google Scholar
  124. Olsnes S, Sandvig K (1988) How protein toxins enter and kill cells. In: Frankel AE (ed) Immunotoxins. Kluwer, Boston, pp 39–73CrossRefGoogle Scholar
  125. Olsnes S, Fernandez-Puentes C, Carrasco L, Vazquez D (1975) Ribosome inactivation by the toxic lectins abrin and ricin. Kinetics of the enzymatic activity of the toxin A-chains. Eur J Biochem 60: 281–288PubMedCrossRefGoogle Scholar
  126. Olsnes S, Reisbig R, Eiklid K (1981) Subunit structure of Shigella toxin. J Biol Chem 256: 8732–8738PubMedGoogle Scholar
  127. Ostroff SM, Tarr PI, Neill MA, Lewis JH, Hargrett-Bean N, Kobayashi JM (1989) Toxin genotypes and plasmid profiles as determinants of systemic sequelae in Escherichia coli 0157: H7 infections. J Infect Dis 160: 994–999PubMedCrossRefGoogle Scholar
  128. Pai CH, Kelly JK, Meyers GL (1986) Experimental infection of infant rabbits with verotoxin-producing Escherichia coli. Infect Immun 51: 16–23PubMedGoogle Scholar
  129. Perera LP, Samuel JE, Holmes RK, O’Brien AD (1991) Identification of three amino acid residues in the B subunit of Shiga toxin and Shiga-like toxin II essential for holotoxin activity. J Bacteriol 173: 1151–1160PubMedGoogle Scholar
  130. Prywes R, Livneh E, Ullrich A, Schlessinger J (1986) Mutations in the cytoplasmic domain of EGF receptor affect EGF binding and receptor internalization. EMBO J 5: 2179–2190PubMedGoogle Scholar
  131. Reisbig R, Olsnes S, Eiklid K (1981) The cytotoxic activity of Shigella toxin. Evidence for catalytic inactivation of the 60 S ribosomal subunit. J Biol Chem 256: 8739–8744PubMedGoogle Scholar
  132. Remis RS, MacDonald KL, Riley LW, Phur ND, Wells JG, David BR, Blake PA, Cohen ML (1984) Sporadic cases of hemorrhagic colitis associated with Escherichia coli 0157: H7. Ann Intern Med 101:624–626PubMedGoogle Scholar
  133. Rietra PJGM, Willshaw GA, Smith HR, Field AM, Scotland SM, Rowe B (1989) Comparison of Vero cytotoxin-encoding phages fromEscherichia coli of human and bovine origin. J Gen Microbiol 135: 2307–2318PubMedGoogle Scholar
  134. Riley LW, Remis RS, Helgerson SD, McGee HB, Wells JG, Davis BR, Hebert RJ, Olcott ES, Johnson LM, Hargrett NT, Blake PA, Cohen ML (1983) Hemorrhagic colitis associated with a rare Escherichia coli serotype. N Engl J Med 308: 681–685PubMedCrossRefGoogle Scholar
  135. Rose PE, Armour JA, Williams CE, Hill FGH (1985) Verotoxin and neuraminidase induced platelet aggregating activity in plasma; their possible role in the pathogenesis of the haemolytic uraemic syndrome. J Clin Pathol 38: 438–441PubMedCrossRefGoogle Scholar
  136. Rothenberger S, lacopetta BJ, Kühn LC (1987) Endocytosis of the transferrin receptor requires the cytoplasmic domain but not its phosphorylation site. Cell 49: 423–431PubMedCrossRefGoogle Scholar
  137. Royall JA, Berkow RL, Beckman JS, Cunningham MK, Matalon S, Freeman BA (1989) Tumor necrosis factor and interleukin 1a increase endothelial permeability. Am J Physiol 257: L399-L410Google Scholar
  138. Ryd M, Alfredsson H, Blomberg L, Andersson A, Lindberg AA (1989) Purification of Shiga toxin by oe-D-galactose-(1 -4)-/?-D-galactose-(1 -4)-/β-D-glucose-(1)-receptor ligand-based chromatography. FEBS Lett 258: 320–322PubMedCrossRefGoogle Scholar
  139. Samuel JE, Perera LP, Ward S, O’Brien AD, Ginsburg V, Krivan HC (1990) Comparison of the glycolipid receptor specificities of Shiga-like toxin type II and Shiga-like toxin type II variants. Infect Immun 58: 611–618PubMedGoogle Scholar
  140. Sandvig K, Brown JE (1987) Ionic requirements for entry of Shiga toxin fromShigella dysenteriae 1 into cells. Infect Immun 55: 298–303PubMedGoogle Scholar
  141. Sandvig K, Olsnes S (1982) Entry of the toxic proteins abrin, modeccin, ricin, and diphtheria toxin into cells. I. Requirement for calcium. J Biol Chem 257: 7495–7503PubMedGoogle Scholar
  142. Sandvig K, Tönnessen TL, Olsnes S (1986) Ability of inhibitors of glycosylation and protein synthesis to sensitize cells to abrin, ricin, Shigella toxin, and Pseudomonas toxin. Cancer Res 46: 6418–6422PubMedGoogle Scholar
  143. Sandvig K, Olsnes S, Petersen OW, van Deurs B (1987) Acidification of the cytosol inhibits endocytosis from coated pits. J Cell Biol 105: 679–689PubMedCrossRefGoogle Scholar
  144. Sandvig K, Olsnes S, Petersen OW, van Deurs B (1988) Inhibition of endocytosis from coated pits by acidification of the cytosol. J Cell Biochem 36: 73–81PubMedCrossRefGoogle Scholar
  145. Sandvig K, Olsnes S, Brown JE, Petersen OW, van Deurs B (1989a) Endocytosis from coated pits of Shiga toxin: a glycolipid-binding protein from Shigella dysenteriae 1. J Cell Biol 108:1331–1343PubMedCrossRefGoogle Scholar
  146. Sandvig K, Olsnes S, Petersen OW, van Deurs B (1989b) Control of coated-pit function by cytoplasmic pH. In: Tartakoff AM (ed) Methods in cell biology, vol 32. Vesicular transport, part B. Academic, New York, pp 365–382Google Scholar
  147. Sandvig K, Prydz K, Ryd M, van Deurs B (1991a) Endocytosis and intracellular transport of the glycolipid-binding ligand Shiga toxin in polarized MDCK cells. J Cell Biol 113: 553–562PubMedCrossRefGoogle Scholar
  148. Sandvig K, Prydz K, van Deurs B (1991b) Endocytic uptake of ricin and Shiga toxin. Springer; Berlin Heidelberg New YorkGoogle Scholar
  149. Sansonetti PJ (1991) Genetic and molecular basis of epithelial cell invasion by Shigella species. Rev Infect Dis 13 [Suppl 4]: S285-S292CrossRefGoogle Scholar
  150. Saxena SK, O’Brien AD, Ackerman EJ (1989) Shiga toxin, Shiga-like toxin II variant, and ricin are all single-site RNA N-glycosidases of 28S RNA when microinjected into Xenopus oocytes. J Biol Chem 264: 596–601PubMedGoogle Scholar
  151. Schleimer RP, Rutledge BK (1986) Cultured human vascular endothelial cells acquire adhesiveness for neutrophils after stimulation with interleukin 1, endotoxin, and tumor-promoting phorbol diesters. J Immunol 136: 649–654PubMedGoogle Scholar
  152. Schlossman D, Withers D, Welsh P, Alexander A, Robertus J Frankel A (1989) Role of glutamic acid 177 of the ricin toxin A chain in enzymatic inactivation of ribosomes. Mol Cell Biol 9: 5012–5021PubMedGoogle Scholar
  153. Schmitt CK, McKee ML, O’Brien AD (1991) Two copies of Shiga-like toxin ll-related genes common in enterohemorrhagic Escherichia coli strains are responsible for the antigenic heterogeneity of the 0157: H strain E32511. Infect Immun 59:1065–1073PubMedGoogle Scholar
  154. Scotland SM, Smith HR, Willshaw GA, Rowe B (1983) Vero cytotoxin production in a strain of Escherichia coli determined by genes carried on bacteriophage. Lancet ii: 216CrossRefGoogle Scholar
  155. Seidah NG, Donohue-Rolfe A, Lazure C, AuClair F, Keusch GT, Chretien M (1986) Complete amino acid sequence of Shigella toxin B-chain. J Biol Chem 261:13928–13931PubMedGoogle Scholar
  156. Sekizaki T, Harayama S, Timmis KN (1987) Genetic manipulation in vivo of stx, a determinant essential for high level production of Shiga toxin by Shigella dysenteriae serotype 1: localization nearpyrF and generation of six” transposon mutants. Infect Immun 55: 2208–2214PubMedGoogle Scholar
  157. Shiga K (1898) Ueber den Dysenterie-bacillus (Bacillus dysenteriae). Zentralbl Bakteriol Orig 24:913–918Google Scholar
  158. Shite S, Seguchi T, Mizoguchi H, Ono M, Kuwano M (1990) Differential effects of brefeldin A on sialylation of N- and O-linked oligosaccharides in low density lipoprotein receptor and epidermal growth factor receptor. J Biol Chem 265:17385–17388PubMedGoogle Scholar
  159. Smith HW, Linggood MA (1971) Transmissible nature of enterotoxin production in a human enteropathogenic strain ofEscherichia coli. J Med Microbiol 4: 301–305PubMedCrossRefGoogle Scholar
  160. Smith HW, Green P, Parsell Z (1983) Vero cell toxins in Escherichia coli and related bacteria: transfer by phage and conjugation and toxic action in laboratory animals, chickens, and pigs. J Gen Microbiol 129:3121–3137PubMedGoogle Scholar
  161. Strockbine NA, Marques LRM, Newland JW, Smith HW, Holmes RK, O’Brien AD (1986) Two toxin-converting phages from Escherichia coli 0157: H7 strain 933 encode antigenically distinct toxins with similar biologic activities. Infect Immun 53:135–140PubMedGoogle Scholar
  162. Strockbine NA, Jackson MP, Sung LM, Holmes RK, O’Brien AD (1988) Cloning and sequencing of the genes for Shiga toxin from Shigella dysenteriae type 1. J Bacteriol 170:1116–1122PubMedGoogle Scholar
  163. Sung LM, Jackson MP, O’Brien AD, Holmes PK (1990) Analysis of transcription of the Shiga-like toxin type II and Shiga-like toxin type II variant operons of Escherichia coli. J Bacteriol 172:6386–6395PubMedGoogle Scholar
  164. Takami N, Oda K, Fujiwara T, Ikehara Y (1990) Intracellular accumulation and oligosaccharide processing of alkaline phosphatase under disassembly of the Golgi complex caused by brefeldin A. Eur J Biochem 194: 805–810PubMedCrossRefGoogle Scholar
  165. Takao T, Tanabe T, Hong Y-M, Shimonishi Y, Kurazono H, Yutsudo T, Sasakawa C, Yoshikawa M, Takeda Y (1988) Identity of molecular structure of Shiga-like toxin I (VT1) from Escherichia coli 0157: H7 with that of Shiga toxin. Microb Pathog 5: 357–369CrossRefGoogle Scholar
  166. Tesh VL, O’Brien AD (1991) The pathogenic mechanisms of Shiga toxin and the Shiga-like toxins. Mol Microbiol 5: 1817–1822PubMedCrossRefGoogle Scholar
  167. Tesh VL, Samuel JE, Perera LP, Sharefkin JB, O’Brien AD (1991) Evaluation of the role of Shiga and Shiga-like toxins in mediating direct damage of human vascular endothelial cells. J Infect Dis 164: 344–352PubMedCrossRefGoogle Scholar
  168. Thompson MR, Steinberg MS, Gemski P, Formal SB, Doctor BP (1976) Inhibition of in vitro protein synthesis by Shigella dysenteriae 1 toxin. Biochem Biophys Res Commun 71: 783–788PubMedCrossRefGoogle Scholar
  169. Timmis KN, Clayton CL, Sekizaki T (1985) Localization of Shiga toxin gene in the region of Shigella dysenteriae 1 chromosome specifying virulence functions. FEMS Lett 30: 301–305CrossRefGoogle Scholar
  170. Tran D, Carpentier JL, Sawano F, Görden P, Orci L (1987) Ligands internalized through coated or noncoated invaginations follow a common intracellular pathway. Proc Natl Acad Sci USA 84: 7957–7961PubMedCrossRefGoogle Scholar
  171. van Deurs B, Petersen OW, Olsnes S, Sandvig K (1987) Delivery of internalized ricin from endosomes to cisternal Golgi elements is a discontinuous, temperature-sensitive process. Exp Cell Res 171:137–152PubMedCrossRefGoogle Scholar
  172. van Deurs B, Petersen OW, Olsnes S, Sandvig K (1989) The ways of endocytosis. Int Rev Cytol 117: 131–177PubMedCrossRefGoogle Scholar
  173. van Heyningen WE, Gladstone GP (1953a) The neurotoxin of Shigella shigae. 1. Production, purification and properties of the toxin. Br J Exp Pathol 34: 202–216Google Scholar
  174. van Heyningen WE, Gladstone GP (1953b) The neurotoxin of Shigella shigae. 3. The effect of iron on production of the toxin. Br J Exp Pathol 34: 221–229Google Scholar
  175. van Hinsbergh VWM, Kooistra T, Vanderberg EA, Princer HK/IG, Fiers W, Emeis JJL (1988) Tumor necrosis factor increases the production of plasminogen activator inhibitor in human endothelial cells in vitro and it rats in vivo. Blood 72:1467–1473PubMedGoogle Scholar
  176. Vicari G, Olitzki AL, Olitzki Z (1960) The action of the thermolabile toxin of Shigella dysenteriae on cells cultivatedin vitro. Br J Exp Pathol 41:179–189PubMedGoogle Scholar
  177. von Wulfen H, Russmann H, Karch H, Meyer T, Bitzan M, Kohrt TC, Aleksic S (1989) Verocytotoxin-producing Escherichia coli 02: H5 isolated from patients with ulcerative colitis. Lancet i: 1449–1450CrossRefGoogle Scholar
  178. Waddell T, Head S, Petric M, Cohen A, Lingwood C (1988) Globotriosyl ceramide is specifically recognized by the Escherichia coli verocytotoxin 2. Biochem Biophys Res Commun 152: 674–679PubMedCrossRefGoogle Scholar
  179. Waddell T, Cohen A, Lingwood CA (1990) Induction of verotoxin sensitivity in receptor-deficient cell lines using the receptor glycolipid globotriaosyl-ceramide. Proc Natl Acad Sci (USA) 87: 7898–7901CrossRefGoogle Scholar
  180. Wadolkowski EA, Burris JA, O’Brien AD (1990a) Mouse model for colonization and disease caused by enterohemorrhagic Escherichia coli. Infect Immun 58: 2438–2445PubMedGoogle Scholar
  181. Wadolkowski EA, Sung LM, Burris JA, Samuel JE, O’Brien AD (1990b) Acute renal tubular necrosis and death of mice orally infected with Escherichia coli strains that produce Shiga-like toxin type II. Infect Immun 58: 3959–3965PubMedGoogle Scholar
  182. Weinstein DL, Holmes RK, O’Brien AD (1988a) Effect of iron and temperature on Shiga-like toxin I production by Escherichia coli. Infect Immun 56:106–111PubMedGoogle Scholar
  183. Weinstein DL, Jackson MP, Samuel JE, Holmes RK, O’Brien AD (1988b) Cloning and sequencing of a Shiga-like toxin II variant from an Escherichia coli strain responsible for edema disease of swine. J Bacteriol 170: 4223–4230PubMedGoogle Scholar
  184. Weinstein DL, Jackson MP, Perera LP, Holmes RK, O’Brien AD (1989) In vivo formation of hybrid toxins comprised of Shiga toxin and the Shiga-like toxins and the role of the B subunit in localization and cytotoxic activity. Infect Immun 57: 3743–3750PubMedGoogle Scholar
  185. Wells JG, Davis BR, Wachsmuth IK, Riley LW, Remis RS, Sokolow R, Morris GK (1983) Laboratory investigation of hemorrhagic colitis outbreaks associated with a rareEscherichia coli serotype. J Clin Microbiol 18:512–520PubMedGoogle Scholar
  186. Willshaw GA, Smith HR, Scotland SM, Field AM, Rowe B (1985) Cloning of genes determining the production of Vero cytotoxin by Escherichia coli. J Gen Microbiol 131: 3047–3053PubMedGoogle Scholar
  187. Willshaw GA, Smith HR, Scotland SM, Field AM, Rowe B (1987) Heterogeneity ofEscherichia coli phages encoding Vero cytotoxins: comparison of cloned sequences determining VT1 and VT2 and development of specific gene probds. J Gen Microbiol 133:1309–1317PubMedGoogle Scholar
  188. Yutsudo T, Hondo T, Miwatani T, Takeda Y (1986) Characterization of purified Shiga toxin from Shigella dysenteriae I. Microbiol Immunol 30:1115–1127PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1992

Authors and Affiliations

  • A. D. O’brien
    • 1
  • V. L. Tesh
    • 1
  • A. Donohue-Rolfe
    • 2
  • M. P. Jackson
    • 3
  • S. Olsnes
    • 4
  • K. Sandvig
    • 4
  • A. A. Lindberg
    • 5
  • G. T. Keusch
    • 2
  1. 1.Department of Microbiology, F. Edward Hébert School of MedicineUniformed Services University of the Health SciencesBethesdaUSA
  2. 2.Department of Medicine, Division of Geographic Medicine and Infectious DiseasesNew England Medical Center Hospitals, Tufts University School of MedicineBostonUSA
  3. 3.Department of Immunology and MicrobiologyWayne State University School of MedicineDetroitUSA
  4. 4.Department of BiochemistryInstitute for Cancer ResearchMontebello, Oslo 3Norway
  5. 5.Department of Clinical BacteriologyHuddinge University HospitalHuddingeSweden

Personalised recommendations